Gene · 7301
Papers2,825
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
361 to 380 of 2,825
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Detection of germline variants with pathogenic potential in 48 patients with familial colorectal cancer by using whole exome sequencing. | BMC Med Genomics | 2023 | 37296477 | PubTator, text mining | PubMed |
Children's, parents', and teachers' experiences of the feasibility of a telerehabilitation intervention for children with acquired brain injury in the chronic phase - a qualitative study of acceptability and participation in the Child In Context Intervention (CICI). | BMC Health Serv Res | 2023 | 37291543 | PubTator, text mining | PubMed |
| Characterization of stemness features and construction of a stemness subtype classifier to predict survival and treatment responses in lung squamous cell carcinoma. | BMC Cancer | 2023 | 37291533 | PubTator, text mining | PubMed |
| Polypharmacology: promises and new drugs in 2022. | Pharmacol Rep | 2023 | 37278927 | PubTator, text mining | PubMed |
| Subjective experiences during dexmedetomidine- or propofol-induced unresponsiveness and non-rapid eye movement sleep in healthy male subjects. | Br J Anaesth | 2023 | 37268445 | PubTator, text mining | PubMed |
| Gas6/AXL pathway: immunological landscape and therapeutic potential. | Front Oncol | 2023 | 37265798 | PubTator, text mining | PubMed |
| EMT/MET plasticity in cancer and Go-or-Grow decisions in quiescence: the two sides of the same coin? | Mol Cancer | 2023 | 37259089 | PubTator, text mining | PubMed |
| Vitamin K supplementation and vascular calcification: a systematic review and meta-analysis of randomized controlled trials. | Front Nutr | 2023 | 37252246 | PubTator, text mining | PubMed |
| Gas6/Axl Axis Activation Dampens the Inflammatory Response in Osteoarthritic Fibroblast-like Synoviocytes and Synovial Explants. | Pharmaceuticals (Basel) | 2023 | 37242486 | PubTator, text mining | PubMed |
| Acute Myeloid Leukemia Causes Serious and Partially Irreversible Changes in Secretomes of Bone Marrow Multipotent Mesenchymal Stromal Cells. | Int J Mol Sci | 2023 | 37240298 | PubTator, text mining | PubMed |
| Decoding the Human Epidermal Complexity at Single-Cell Resolution. | Int J Mol Sci | 2023 | 37239891 | PubTator, text mining | PubMed |
| Client predictors of therapy dropout in a primary care setting: a prospective cohort study. | BMC Psychiatry | 2023 | 37226210 | PubTator, text mining | PubMed |
| The role of mitochondria in the resistance of melanoma to PD-1 inhibitors. | J Transl Med | 2023 | 37221594 | PubTator, text mining | PubMed |
| Overexpression of TYRO3 indicates poor prognosis and induces gastric cancer progression via AKT-mTOR pathway. | Mol Carcinog | 2023 | 37212497 | PubTator, text mining | PubMed |
Adequacy of the examination-based licensing system and a training-based licensing system for midwifery license according to changes in childbirth medical infrastructure in Korea: a surveybased descriptive study | J Educ Eval Health Prof | 2023 | 37211982 | PubTator, text mining | PubMed |
| Functional and Clinical Proteomic Exploration of Pancreatic Cancer. | Mol Cell Proteomics | 2023 | 37209817 | PubTator, text mining | PubMed |
| Stress granules: potential therapeutic targets for infectious and inflammatory diseases. | Front Immunol | 2023 | 37205103 | PubTator, text mining | PubMed |
| Making the Best Use of Available Weapons for the Inevitable Rivalry-Resistance to EGFR-TKIs. | Biomedicines | 2023 | 37189759 | PubTator, text mining | PubMed |
| A Comprehensive Narrative Review on the History, Current Landscape, and Future Directions of Hepatocellular Carcinoma (HCC) Systemic Therapy. | Cancers (Basel) | 2023 | 37173972 | PubTator, text mining | PubMed |
| PRAME Is a Novel Target of Tumor-Intrinsic Gas6/Axl Activation and Promotes Cancer Cell Invasion in Hepatocellular Carcinoma. | Cancers (Basel) | 2023 | 37173882 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7301/papers?page=19